Topical delivery of pluronic F127/TPGS mixed micelles-based hydrogel loaded with glycyrrhizic acid for atopic dermatitis treatment

References

• Sinéad ML, Alan DI, Stephan W. Atopic dermatitis. Lancet. 2020;396:345–360.
   PubMedGoogle Scholar
• Oliveira C, Torres T. More than skin deep: the systemic nature of atopic dermatitis. Eur J Dermatol. 2019;29(3):250–258.
   PubMed Web of Science ®Google Scholar
• Torres T, Ferreira EO, Gonçalo M, et al. Update on atopic dermatitis. Acta Med Port. 2019;32(9):606–613.
   PubMed Web of Science ®Google Scholar
• Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1.
   PubMed Web of Science ®Google Scholar
• Kwon CY, Lee B, Kim S, et al. Effectiveness and safety of herbal medicine for atopic dermatitis: an overview of systematic reviews. Evid Based Complement Alternat Med. 2020;2020:4140692.
   PubMed Web of Science ®Google Scholar
• Yan F, Li F, Liu JF, et al. The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis. Biomed Pharmacother. 2020;127:110142.
   PubMedGoogle Scholar
• Chen K, Yang R, Shen FQ, et al. Advances in pharmacological activities and mechanisms of glycyrrhizic acid. Curr Med Chem. 2020;27(36):6219–6243.
   PubMed Web of Science ®Google Scholar
• Rehman MU, Farooq A, Ali R, et al. Preclinical evidence for the pharmacological actions of glycyrrhizic acid: a comprehensive review. Curr Drug Metab. 2020;21(6):436–465.
   PubMedGoogle Scholar
• Li JY, Cao HY, Liu P, et al. Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed Res Int. 2014;2014:872139.
   PubMed Web of Science ®Google Scholar
• Sun ZG, Zhao TT, Lu N, et al. Research progress of glycyrrhizic acid on antiviral activity. Mini Rev Med Chem. 2019;19(10):826–832.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Peng G, et al. Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1. Int Immunopharmacol. 2018;60:9–17.
   PubMed Web of Science ®Google Scholar
• Lee SH, Bae IH, Choi H, et al. Ameliorating effect of dipotassium glycyrrhizinate on an IL-4- and IL-13-induced atopic dermatitis-like skin-equivalent model. Arch Dermatol Res. 2019;311(2):131–140.
   PubMedGoogle Scholar
• Ye HQ, Zhou JW, Yang XY. Therapeutic effect of compound glycyrrhizin tablets on pediatric atopic dermatitis. J Dermatol Venereol. 2018;40:160–161.
   Google Scholar
• Tu CX, Zhang XJ, Zhang YY. Clinical and experimental study on treatment of atopic dermatitis with glycyrrhizin. China J Lepr Skin Dis. 2007;23:393–395.
   Google Scholar
• Barone A, Cristiano MC, Cilurzo F, et al. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: a novel use as an anti-inflammatory agent in topical drug delivery. Colloids Surf B Biointerfaces. 2020;193:111152.
   PubMed Web of Science ®Google Scholar
• Yamamoto R, Takasuga S, Kominami K, et al. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers. Chem Pharm Bull. 2013;61(12):1275–1281.
   PubMedGoogle Scholar
• Shabbir M, Nagra U, Zaman M, et al. Lipid vesicles and nanoparticles for non-invasive topical and transdermal drug delivery. Curr Pharm Des. 2020;26(18):2149–2166.
   PubMed Web of Science ®Google Scholar
• Campos E, Proença P, Doretto-Silva L, et al. Trends in nanoformulations for atopic dermatitis treatment. Expert Opin Drug Deliv. 2020;17(11):1615–1630.
   PubMedGoogle Scholar
• Amasya G, Inal O, Sengel-Turk CT. SLN enriched hydrogels for dermal application: full factorial design study to estimate the relationship between composition and mechanical properties. Chem Phys Lipids. 2020;228:104889.
   PubMedGoogle Scholar
• Gokhale JP, Mahajan HS, Surana SJ. Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies. Biomed Pharmacother. 2019;112:108622.
   PubMed Web of Science ®Google Scholar
• Shen C, Xu P, Shen B, et al. Nanogel for dermal application of the triterpenoids isolated from Ganoderma lucidum (GLT) for frostbite treatment. Drug Deliv. 2016;23(2):610–618.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Taymouri S, Minaiyan M, et al. Development and in vitro/in vivo evaluation of HPMC/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent. Drug Dev Ind Pharm. 2018;44(2):276–288.
   PubMed Web of Science ®Google Scholar
• Cagel M, Tesan F, Bernabeu E, et al. Polymeric mixed micelles as nanomedicines: achievements and perspectives. Eur J Pharm Biopharm. 2017;113:211–228.
   PubMed Web of Science ®Google Scholar
• Shen CY, Zhu JJ, Song JW, et al. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid. Drug Dev Ind Pharm. 2020;46(7):1100–1107.
   PubMed Web of Science ®Google Scholar
• Shen CY, Shen BD, Zhu JJ, et al. Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. Drug Dev Ind Pharm. 2021;47(2):207–214.
   PubMed Web of Science ®Google Scholar
• Shen C, Shen B, Liu X, et al. Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability. J Drug Deliv Sci Technol. 2018;43:1–11.
   Web of Science ®Google Scholar
• Yogeshwar GB, Vandana BP. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 2009;365:175–179.
   PubMedGoogle Scholar
• Geetanjali BSP, Singh D, Bedi N. Microemulsion based hydrogel of tacrolimus for the treatment of atopic dermatitis. Pharm Nanotechnol. 2016;4(2):136–154.
   Google Scholar
• Pal RR, Parashar P, Singh I, et al. Tamanu oil potentiated novel sericin emulgel of levocetirizine: repurposing for topical delivery against DNCB-induced atopic dermatitis, QbD based development and in vivo evaluation. J Microencapsul. 2019;36(5):432–446.
   PubMedGoogle Scholar
• Fan PL, Yan YL, Liu T, et al. Anti-atopic effect of viola yedoensis ethanol extract against 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction. J Ethnopharmacol. 2021;280:114474.
   PubMedGoogle Scholar
• Lee HJ, Kim MH, Choi YY, et al. Improvement of atopic dermatitis with topical application of Spirodela polyrhiza. J Ethnopharmacol. 2016;180:12–17.
   PubMed Web of Science ®Google Scholar
• Wu BW, Yang XH, Zhan RZ. Effects of glycyrrhizin on skin barrier function in atopic dermatitis mice. Chin J Clin Pharmacol. 2020;36:1324–1327.
   Google Scholar
• Wang YX, Cao SS, Yu KY, et al. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects. Int J Nanomedicine. 2019;14:5849–5863.
   PubMed Web of Science ®Google Scholar
• Yu HY, Li HY, Li YX, et al. Effect of isoliquiritigenin for the treatment of atopic dermatitis-like skin lesions in mice. Arch Dermatol Res. 2017;309(10):805–813.
   PubMedGoogle Scholar
• Boothe WD, Tarbox JA, Tarbox MB. Atopic dermatitis: pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.
   PubMedGoogle Scholar
• Furue M, Chiba T, Tsuji G, et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 2017;66(3):398–403.
   PubMed Web of Science ®Google Scholar
• Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol. 2011;41(3):298–310.
   PubMed Web of Science ®Google Scholar
• Jiang JZ, Ma TY, Zhang LH, et al. The transdermal performance, pharmacokinetics, and anti-inflammatory pharmacodynamics evaluation of harmine-loaded ethosomes. Drug Dev Ind Pharm. 2020;46(1):101–108.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603–618.
   PubMed Web of Science ®Google Scholar
• Hatahet T, Morille M, Hommoss A, et al. Dermal quercetin smartCrystals®: formulation development, antioxidant activity and cellular safety. Eur J Pharm Biopharm. 2016;102:51–63.
   PubMed Web of Science ®Google Scholar
• Carrer V, Alonso C, Pont M, et al. Effect of propylene glycol on the skin penetration of drugs. Arch Dermatol Res. 2020;312(5):337–352.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Gulati N, Nagaich U. Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery. Int J Polym Mater. 2018;68(2):1–12.
   Google Scholar
• Assem M, Khowessah OM, Ghorab D. Optimization and evaluation of beclomethasone dipropionate micelles incorporated into biocompatible hydrogel using a sub-chronic dermatitis animal model. AAPS PharmSciTech. 2019;20(4):152.
   PubMedGoogle Scholar
• Tarl WP, Jeffrey EG, Lynlee LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011;63:470–491.
   PubMedGoogle Scholar
• Lademann J, Richter H, Teichmann A, et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66(2):159–164.
   PubMed Web of Science ®Google Scholar
• Liou YB, Ho HO, Chen SY, et al. Correlation of the penetration enhancement with the influence of an alcohol/tocopheryl polyethylene glycol succinate (TPGS) cosolvent system on the molecular structure of the stratum corneum of nude mouse skin as examined by microscopic FTIR/DSC. Spectrochim Acta A Mol Biomol Spectrosc. 2009;74(3):695–703.
   PubMedGoogle Scholar
• Sheu MT, Chen SY, Chen LC, et al. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. J Control Release. 2003;88(3):355–368.
   PubMedGoogle Scholar
• Khan M, Khan SA, Ubaid M, et al. Finasteride topical delivery systems for androgenetic alopecia. Curr Drug Deliv. 2018;15(8):1100–1111.
   PubMed Web of Science ®Google Scholar
• Lee SG, Kim SR, Cho HI, et al. Hydrogel-based ultra-moisturizing cream formulation for skin hydration and enhanced dermal drug delivery. Biol Pharm Bull. 2014;37(10):1674–1682.
   PubMedGoogle Scholar
• Salatin S, Jelvehgari M. Desirability function approach for development of a thermosensitive and bioadhesive nanotransfersome-hydrogel hybrid system for enhanced skin bioavailability and antibacterial activity of cephalexin. Drug Dev Ind Pharm. 2020;46(8):1318–1333.
   PubMed Web of Science ®Google Scholar